A fatal case of inappropriate adh secretion induced by cyclophosphamide therapy
- 1 September 1979
- Vol. 44 (3) , 896-898
- https://doi.org/10.1002/1097-0142(197909)44:3<896::aid-cncr2820440316>3.0.co;2-9
Abstract
Cyclophosphamide is used extensively to treat malignancies. A 5-year-old boy with stage IV neuroblastoma is described who developed a fatal syndrome of inappropriate antidiuretic hormone (ADH) secretion after high dose cyclophosphamide therapy.This publication has 4 references indexed in Scilit:
- NEUROLOGICAL MANIFESTATIONS AND MORBIDITY OF HYPONATREMIA: CORRELATION WITH BRAIN WATER AND ELECTROLYTESMedicine, 1976
- The Clinical Pharmacology of Antineoplastic AgentsNew England Journal of Medicine, 1975
- Water Intoxication in Man After Cyclophosphamide TherapyAnnals of Internal Medicine, 1973
- High-dose cyclophosphamide therapy for malignant disease.Toxicity, tumor response, and the effects of stored autologous marrowCancer, 1972